Labetalol Hydrochloride
77 NDCs across 20 manufacturers|77 Generic,0 Brand
Labetalol Hydrochloride is used to treat angina pectoris, heart failure, malignant hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 1, 1984, and the first generic was approved Aug 3, 1998. FDA's Orange Book lists 35 AB-rated (therapeutically equivalent) products for this ingredient.
Labetalol Hydrochloride is available as 77 NDCs from 20 manufacturers (77 generic, 0 brand), with NADAC prices from $0.08 to $1.55 per EA — the most expensive product costs about 19× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
77
77G / 0B
Manufacturers
20
competing in market
Price Spread
$0.08 – $1.55
per EA, 69 of 77 NDCs
7d Activity
avg -2.0% WoW · of 77 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Biocon Pharma Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta-Adrenergic Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
20 manufacturers producing LABETALOL HYDROCHLORIDE(1 pricing outlier)
Frequently Asked Questions
What is Labetalol Hydrochloride used to treat?
Labetalol Hydrochloride is used to treat angina pectoris, heart failure, malignant hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Labetalol Hydrochloride become available as a generic?
FDA approved the first generic Labetalol Hydrochloride (ANDA) on Aug 3, 1998. The Orange Book currently lists 35 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Labetalol Hydrochloride products are on the market?
The Labetalol Hydrochloride drug market contains 77 NDCs from 20 manufacturers — 77 generic and 0 brand products.
What is the price range for Labetalol Hydrochloride?
NADAC reference prices for Labetalol Hydrochloride range from $0.0807 to $1.5525 per EA — the most expensive product costs about 19× the cheapest. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Labetalol Hydrochloride?
20 manufacturers list Labetalol Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Biocon Pharma Inc. (8), Advagen Pharma Ltd. (7), Method Pharmaceuticals LLC (6), Heritage Pharmaceuticals Inc. (6), Zydus Pharmaceuticals (USA) Inc. (6).
How has the price of Labetalol Hydrochloride changed recently?
Over the past 7 days, 2 Labetalol Hydrochloride NDCs rose and 56 fell, with a market-wide average change of -2.0%.